• Annovis Bio Completes Enrollment in Pivotal Alzheimer’s Trial TipRanks Fri, 10 Jul 2026 10:39:15 GMT
• Annovis Reaches Full Enrollment in Phase 3 Buntanetap Trial, 850 Patients Enrolled TradingView Fri, 10 Jul 2026 10:13:00 GMT
• Annovis Bio (NYSE: ANVS) completes enrollment in 850-patient Phase 3 Alzheimer’s study Stock Titan Fri, 10 Jul 2026 10:03:18 GMT
• Analysts’ Top Healthcare Picks: Evolus (EOLS), Annovis Bio (ANVS) The Globe and Mail Thu, 09 Jul 2026 19:46:58 GMT
• annovis bio enrolls over 850 patients for its next alzheimer's disease trial qz.com Wed, 08 Jul 2026 07:33:09 GMT
• Annovis Bio Enrolls Over 850 Patients for Its Next Alzheimer's Disease Trial Yahoo Finance Tue, 07 Jul 2026 14:51:56 GMT
• The timeline for the key clinical trial data readout of Annovis Bio Inc. has been clarified. Bitget Tue, 07 Jul 2026 13:05:55 GMT
• Annovis Bio Completes Patient Enrollment for Phase 3 Study of Buntanetap in Alzheimer's Disease Moomoo Tue, 07 Jul 2026 12:01:48 GMT
• Annovis Bio completes enrollment in phase 3 Alzheimer’s trial Investing.com Tue, 07 Jul 2026 11:08:28 GMT
• Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease GlobeNewswire Tue, 07 Jul 2026 11:00:00 GMT
• The buntanetap program - Annovis Bio bets on neurodegeneration trials ad-hoc-news.de Sat, 04 Jul 2026 22:38:45 GMT
• Annovis Bio Promotes Cheng Fang to Chief Scientific Officer Ahead of Phase 3 Milestones citybiz Wed, 01 Jul 2026 12:45:32 GMT
• Press Release: Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer Moomoo Wed, 01 Jul 2026 12:01:00 GMT
• Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer Yahoo Finance Wed, 01 Jul 2026 12:00:00 GMT
• Annovis elevates its R&D chief as Phase 3 Alzheimer’s data nears Stock Titan Wed, 01 Jul 2026 12:00:00 GMT
• ANVS Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Advances Pipeline - Analyst Consensus Shift dars.gov.et Mon, 29 Jun 2026 13:31:07 GMT
• Annovis Bio, Inc.(NYSE: ANVS) added to Russell 3000E Index marketscreener.com Mon, 29 Jun 2026 06:43:02 GMT
• Annovis Bio, Inc.(NYSE: ANVS) added to Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 05:33:28 GMT
• ANVS Financials: Revenue Breakdown, Margins & Competitor Comparison Intellectia AI Sun, 28 Jun 2026 22:10:30 GMT
• Annovis Bio, Inc.(NYSE: ANVS) added to Russell Microcap Growth Benchmark Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Annovis Bio (ANVS) Shows Resilience With 4.24% Gain, Testing Key Resistance - Beta Neutral Pair dars.gov.et Sun, 28 Jun 2026 02:45:01 GMT
• annovis bio | 144: notice of proposed sale of securities pursuant to rule 144 Moomoo Sat, 27 Jun 2026 12:58:25 GMT
• enterprise value to ebitda forward of annovis bio, inc. – nyse:anvs TradingView Thu, 25 Jun 2026 21:24:52 GMT
• ANVS Q1 2026 Earnings: EPS Misses Estimates as Drug Development Costs Continue - Revenue Warning Signal dars.gov.et Thu, 25 Jun 2026 07:00:00 GMT
• annovis bio q1 2026 earnings: eps misses wide expectations as pre-revenue biotech advances pipeline - earnings risk report dars.gov.et Wed, 24 Jun 2026 07:00:00 GMT
• annovis bio q1 2026 earnings: wider-than-expected loss amid zero revenue - dividend earnings report dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• annovis bio inc (anvs) technical analysis: support, resistance, indicators & moving averages TradingKey Sun, 21 Jun 2026 07:00:00 GMT
• annovis bio shareholders approve governance and compensation changes The Globe and Mail Thu, 18 Jun 2026 22:50:00 GMT
• annovis bio inc (anvs) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 11:31:07 GMT
• Why Annovis’ buntanetap pill is drawing fresh attention in Alzheimer’s race ad-hoc-news.de Thu, 18 Jun 2026 07:00:00 GMT
• annovis bio shareholders approve all proposals at annual meeting by investing.com Investing.com Australia Thu, 18 Jun 2026 07:00:00 GMT
• annovis bio inc (anvs) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 21:59:12 GMT
• annovis bio inc (anvs) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 21:48:52 GMT
• annovis bio inc (anvs) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 21:23:36 GMT
• annovis bio inc (anvs) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 14:28:44 GMT
• annovis bio inc (anvs) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 11:17:44 GMT
• annovis bio inc (anvs) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 10:48:57 GMT
• Annovis Bio shareholders approve all proposals at annual meeting Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Annovis Bio (NYSE: ANVS) holders expand equity plan and set biennial say-on-pay Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• annovis bio inc (anvs) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• annovis bio inc (anvs) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• press release: annovis announces pricing of $15.0 million public offering of common stock and accompanying warrants 富途牛牛 Sun, 14 Jun 2026 12:01:59 GMT
• Annovis Bio Inc Stock (US0360431013): Short Interest Climbs At End Of May ad-hoc-news.de Wed, 10 Jun 2026 07:00:00 GMT
• maxim group maintains annovis bio(anvs.us) with buy rating, maintains target price $8 Moomoo Fri, 29 May 2026 07:00:00 GMT
• Maxim Group Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $8 Moomoo Thu, 28 May 2026 07:00:00 GMT
• annovis bio regains nyse listing compliance by investing.com Investing.com South Africa Tue, 26 May 2026 12:42:52 GMT
• Biotech Annovis keeps NYSE listing after falling below $50M thresholds Stock Titan Tue, 26 May 2026 07:00:00 GMT
• annovis bio director michael hoffman buys $142,778 in shares by investing.com Investing.com Nigeria Fri, 22 May 2026 07:00:00 GMT
• anvs technical analysis | trend, signals & chart patterns | annovis bio (nyse:anvs) ChartMill Fri, 22 May 2026 07:00:00 GMT
• 3 parkinson's biotech stocks analysts think are wildly mispriced Moomoo Fri, 22 May 2026 00:58:45 GMT
• director michael hoffman adds 76,344 annovis bio (anvs) shares in open-market buys Stock Titan Fri, 22 May 2026 00:25:09 GMT
• Director Michael Hoffman adds 76,344 Annovis Bio (ANVS) shares in open-market buys Stock Titan Thu, 21 May 2026 07:00:00 GMT
• Annovis Bio director Michael Hoffman buys $142,778 in shares Investing.com Thu, 21 May 2026 07:00:00 GMT
• Annovis Bio | 4: Statement of changes in beneficial ownership of securities-Director Hoffman Michael B Moomoo Thu, 21 May 2026 07:00:00 GMT
• 3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced Moomoo Thu, 21 May 2026 07:00:00 GMT
• annovis bio launches ~$15 million stock-and-warrant offering underwritten by canaccord genuity TradingView Wed, 20 May 2026 20:23:01 GMT
• annovis bio prices $15 million public offering to fund neurodegenerative disease trials MEXC Wed, 20 May 2026 16:12:15 GMT
• annovis bio announces common stock and warrants offering, no amount given TipRanks Wed, 20 May 2026 08:03:39 GMT
• Annovis Bio (NYSE: ANVS) prices $15M common stock and warrant offering Stock Titan Wed, 20 May 2026 07:00:00 GMT
• Annovis Bio prices $15 million public offering at $1.90 Investing.com Wed, 20 May 2026 07:00:00 GMT
• Annovis Bio (NYSE: ANVS) raises $13.8M via 7.895M-share offering and warrants Stock Titan Wed, 20 May 2026 07:00:00 GMT
• annovis announces pricing of $15.0 million public offering of common stock and accompanying warrants GlobeNewswire Wed, 20 May 2026 07:00:00 GMT
• biotech annovis prices $15m offer to fund alzheimer’s, parkinson’s studies Stock Titan Wed, 20 May 2026 07:00:00 GMT
• 12 health care stocks moving in wednesday's pre-market session Benzinga Wed, 20 May 2026 07:00:00 GMT
• annovis bio stock tumbles on public offering announcement by investing.com Investing.com Australia Wed, 20 May 2026 07:00:00 GMT
• press release: annovis announces pricing of $15.0 million public offering of common stock and accompanying warrants Moomoo Wed, 20 May 2026 07:00:00 GMT
• annovis bio launches proposed stock, warrant offering; shares fall Moomoo Wed, 20 May 2026 01:57:11 GMT
• annovis bio announces public offering of stock and warrants by investing.com Investing.com South Africa Wed, 20 May 2026 00:49:09 GMT
• Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants GlobeNewswire Tue, 19 May 2026 07:00:00 GMT
• Annovis Bio announces public offering of stock and warrants Investing.com Tue, 19 May 2026 07:00:00 GMT
• annovis bio stock tumbles on public offering announcement Investing.com Tue, 19 May 2026 07:00:00 GMT
• 12 health care stocks moving in tuesday's after-market session Benzinga Tue, 19 May 2026 07:00:00 GMT
• biotech annovis plans stock-and-warrant sale for alzheimer’s phase 3 study Stock Titan Tue, 19 May 2026 07:00:00 GMT
• annovis bio launches proposed stock, warrant offering; shares fall Moomoo Tue, 19 May 2026 07:00:00 GMT
• annovis bio (anvs) registers equity units with detachable warrants in shelf supplement Stock Titan Tue, 19 May 2026 07:00:00 GMT
• the future of longevity medicine — longevity news roundup — week 19, 2026 Longevity.Technology Mon, 18 May 2026 07:00:00 GMT
• annovis bio, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Fri, 15 May 2026 20:01:00 GMT
• Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results GlobeNewswire Fri, 15 May 2026 07:00:00 GMT
• Press Release: Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results Moomoo Fri, 15 May 2026 07:00:00 GMT
• annovis bio, inc. 1q 2026: net income $(17.61m), eps $(0.63) — 10-q summary TradingView Fri, 15 May 2026 07:00:00 GMT
• annovis bio inc reports results for the quarter ended december 31 - earnings summary TradingView Fri, 15 May 2026 07:00:00 GMT
• annovis bio (nyse: anvs) ramps r&d as phase 3 alzheimer’s trial advances Stock Titan Fri, 15 May 2026 07:00:00 GMT
• rising r&d and going-concern risk at annovis bio (anvs) as cash falls Stock Titan Fri, 15 May 2026 07:00:00 GMT
• experimental alzheimer’s pill nears full trial enrollment, fda talks in 2027 Stock Titan Fri, 15 May 2026 07:00:00 GMT
• malvern company closes $10m offering to extend alzheimer’s therapy testing Pennsylvania Business Report - Wed, 13 May 2026 05:12:26 GMT
• anvs technical analysis | trend, signals & chart patterns | annovis bio (nyse:anvs) ChartMill Mon, 11 May 2026 07:00:00 GMT
• annovis bio ceo to present multi-protein approach to alzheimer’s at fierce biotech week MEXC Exchange Thu, 07 May 2026 20:14:22 GMT
• Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026 Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• the future of longevity medicine — longevity news roundup — week 19, 2026 Longevity.Technology Thu, 07 May 2026 07:00:00 GMT
• Buntanetap gains ground in new Alzheimer’s trial results Longevity.Technology Mon, 04 May 2026 07:00:00 GMT
• annovis bio appoints accomplished neuroscientist, dr. cheng fang as vp of research TMX Newsfile Fri, 01 May 2026 15:17:03 GMT
• anvs earnings history & surprises | eps & revenue results | annovis bio (nyse:anvs) ChartMill Fri, 01 May 2026 07:00:00 GMT
• annovis bio (anvs) seeks approval to expand 2019 equity incentive plan at 2026 meeting Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• noted annovis alzheimer’s trial results published in nature The Clinical Trial Vanguard Wed, 29 Apr 2026 08:03:31 GMT
• annovis bio, inc. (nyse:anvs) sees significant increase in short interest MarketBeat Tue, 28 Apr 2026 10:35:59 GMT
• annovis bio announces transfer of listing to the new york stock exchange TMX Newsfile Tue, 28 Apr 2026 07:05:33 GMT
• Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio GlobeNewswire Tue, 28 Apr 2026 07:00:00 GMT
• Annovis drug showed cognition gains in early AD; 80% enrolled in Phase 3 Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• annovis bio reports positive cognition data in early alzheimer’s trial Investing.com Tue, 28 Apr 2026 07:00:00 GMT
• annovis bio reports positive cognition results in early alzheimer’s trial Investing.com Tue, 28 Apr 2026 07:00:00 GMT
• annovis bio inc publishes phase 2/3 alzheimer's trial results in nature portfolio marketscreener.com Tue, 28 Apr 2026 07:00:00 GMT
• annovis bio announces positive fda feedback for buntanetap phase 3 clinical development in parkinson's disease TMX Newsfile Tue, 28 Apr 2026 06:42:08 GMT
• annovis bio presents at international conference on alzheimer's & parkinson (ad/pd 2022) TMX Newsfile Tue, 28 Apr 2026 06:15:57 GMT
• annovis bio to participate in the biotech showcase and h.c. wainwright bioconnect virtual conferences TMX Newsfile Tue, 28 Apr 2026 06:12:06 GMT
• annovis bio announces publication of anvs401 mechanism of action in peer-reviewed pharmaceutics TMX Newsfile Tue, 28 Apr 2026 06:06:14 GMT
• annovis bio presented at the 14th clinical trials on alzheimer's disease conference TMX Newsfile Tue, 28 Apr 2026 06:01:03 GMT
• annovis bio announces presentation at international conference on alzheimer's & parkinson's diseases 2022 TMX Newsfile Tue, 28 Apr 2026 05:46:40 GMT
• Buntanetap treatment in mild to moderate Alzheimer’s disease: phase 2/3 study Nature Mon, 27 Apr 2026 07:00:00 GMT
• annovis bio announces cooperative research and development agreement (crada) with the national institute on aging TMX Newsfile Fri, 24 Apr 2026 06:49:45 GMT
Annovis Bio, Inc(NYSE:ANVS) 
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chron...
Website: http://www.qrpharma.com
Founded: 2008
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends